Magdalena Budzyń | Immunology | Women Researcher Award

Assist. Prof. Dr. Magdalena Budzyń | Immunology | Women Researcher Award

Assist. Prof. Dr. Magdalena Budzyń, Poznan University of Medical Sciences, Poland.

Dr. Magdalena Budzyń is an accomplished researcher and educator specializing in cardiovascular diseases and laboratory diagnostics. With a strong academic foundation from Poznan University of Medical Sciences, she earned her Ph.D. in Medical Sciences and later achieved the prestigious habilitated doctor qualification. Her research focuses on endothelial damage markers and their role in cardiovascular conditions, contributing valuable insights into disease mechanisms. As an Assistant Professor, she has been dedicated to both scientific discovery and mentoring future medical professionals.

Profile

Orcid

Early Academic Pursuits šŸŽ“

Born on April 4, 1982, Dr. Magdalena Budzyń embarked on her academic journey with a passion for medical sciences. Her educational path began at Poznan University of Medical Sciences, where she pursued an in-depth study of laboratory diagnostics. She completed her Ph.D. in Medical Sciences between 2009 and 2013, focusing on the intricate balance between leukocyte elastase and its inhibitor alpha1-antitrypsin in chronic venous insufficiency. With an insatiable curiosity for cardiovascular research, she further advanced her academic credentials by earning a habilitated doctor degree in 2022, exploring circulating markers of endothelial damage and their clinical implications in cardiovascular diseases.

Professional Endeavors šŸ…

Dr. Budzyńā€™s professional career has been a testament to her dedication to medical research and education. She has been an integral part of Poznan University of Medical Sciences since 2007, serving as an Assistant Professor. Prior to that, she gained valuable experience at Poznan Veterinary Institute as a Technical Assistant, where she honed her laboratory and analytical skills. Her expertise in laboratory medicine and medical chemistry has made her a respected academic in her field, contributing significantly to both research and teaching.

Contributions and Research Focus šŸ”¬

Her research primarily revolves around cardiovascular diseases, with a particular emphasis on endothelial damage markers. By investigating the role of these biomarkers, she has provided critical insights into the pathophysiology of vascular disorders. Her work has contributed to the understanding of chronic venous insufficiency and how leukocyte elastase imbalance impacts disease progression. Additionally, her studies in laboratory diagnostics have strengthened the role of clinical biomarkers in predicting and managing cardiovascular conditions.

Accolades and Recognition šŸ†

Dr. Budzyńā€™s academic excellence has been recognized through her habilitated doctor qualification, a prestigious milestone in her career. Her contributions to medical sciences have been acknowledged within the scientific community, as she continues to shape the field of cardiovascular research. Her role as an educator and mentor further amplifies her influence, guiding students toward meaningful research endeavors in laboratory medicine and diagnostics.

Impact and Influence šŸŒ

Beyond academia, Dr. Budzyńā€™s research has a profound impact on the medical field, particularly in improving diagnostic tools for cardiovascular diseases. Her findings contribute to enhanced patient care by identifying key biomarkers that aid in early disease detection and treatment planning. She actively collaborates with researchers and medical professionals, ensuring that her work bridges the gap between scientific discovery and clinical application.

publication

  • Significance of the monocyte CCR2-CCL2 axis in triple-negative breast cancer
    Authors: Magdalena Budzyń, Agata Kubicka, Elżbieta Kaja, Witold Kycler, Joanna Załuska-Kusz, Jacek J. Brzeziński, Marcelina Sperling, Alicja Bukowska, Joanna Grupińska
    Year: 2025

 

  • Nutritional Behaviors, Vitamin Supplementation and Physical Activity among Polish Adults during the COVID-19 Pandemic
    Authors: Bogna Gryszczyńska, Magdalena Budzyń, Joanna Grupińska, Magdalena Paulina Kasprzak, Agnieszka Gryszczyńska
    Year: 2022

 

  • Beneficial Effects of Oral Nutritional Supplements on Body Composition and Biochemical Parameters in Women with Breast Cancer Undergoing Postoperative Chemotherapy: A Propensity Score Matching Analysis
    Authors: Joanna Grupińska, Magdalena Budzyń, Kalina Maćkowiak, Jacek Jakub Brzeziński, Witold Kycler, Ewa Leporowska, Bogna Gryszczyńska, Magdalena Paulina Kasprzak, Maria Iskra, Dorota Formanowicz
    Year: 2021

 

  • Association between clinicopathological features of breast cancer with adipocytokine levels and oxidative stress markers before and after chemotherapy
    Authors: Magdalena Budzyń
    Year: 2021

 

  • Changes in the Nrf2/Keap1 Ratio and PON1 Concentration in Plasma of Patients Undergoing the Left Main Coronary Artery Stenting
    Authors: Magdalena Budzyń
    Year: 2020

 

  • Selected Atherosclerosis-Related Diseases May Differentially Affect the Relationship between Plasma Advanced Glycation End Products, Receptor sRAGE, and Uric Acid
    Authors: Bogna Gryszczyńska, Magdalena Budzyń, Dorota Formanowicz, Maria Wanic-Kossowska, Piotr Formanowicz, Wacław Majewski, Maria Iskra, Magdalena P. Kasprzak
    Year: 2020

 

  • Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension
    Authors: Magdalena Budzyń
    Year: 2019

 

  • The Potential Role of Circulating Endothelial Cells and Endothelial Progenitor Cells in the Prediction of Left Ventricular Hypertrophy in Hypertensive Patients
    Authors: Magdalena Budzyń
    Year: 2019

 

  • Advanced Oxidation Protein Products and Carbonylated Proteins Levels in Endovascular and Open Repair of an Abdominal Aortic Aneurysm: The Effect of Pre-, Intra-, and Postoperative Treatment
    Authors: Bogna Gryszczyńska, Magdalena Budzyń, Dorota Formanowicz, Piotr Formanowicz, Zbigniew Krasiński, Natalia Majewska, Maria Iskra, Magdalena P. Kasprzak
    Year: 2019

 

Conclusion

Dr. Budzyńā€™s contributions to medical sciences extend beyond academia, influencing the fields of laboratory diagnostics and cardiovascular research. Her work has significantly improved the understanding of endothelial dysfunction and biomarker-based diagnostics, paving the way for better clinical applications. With her ongoing dedication to research and education, she continues to inspire the next generation of scientists while striving to make impactful advancements in medical science.

Zewen Cheng | Clinical Medicine | Young Scientist Award

Dr. Zewen Cheng | Clinical Medicine | Young Scientist Award

Dr. Zewen Cheng, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine,Ā  China.

Zewen Chengā€™s career is a testament to his dedication to thoracic surgery, combining expertise in both Western and Traditional Chinese medicine. His academic excellence, professional experience, and research contributions highlight his unwavering commitment to advancing patient care. As a skilled surgeon and educator, he continues to make a significant impact in the medical community. Moving forward, his focus on innovation and mentorship will ensure that his contributions leave a lasting mark on the field of thoracic surgery, inspiring future generations of medical professionals.

Profile

Scopus

 

šŸŽ“ Early Academic Pursuits

Zewen Cheng embarked on his medical journey with a passion for thoracic surgery, earning a Master of Medicine in Thoracic Surgery from Soochow University in Suzhou, China. Graduating in 2019, he dedicated himself to mastering the complexities of thoracic diseases, developing a strong foundation in both clinical and surgical practices. His academic years were marked by rigorous training and an unwavering commitment to patient care, setting the stage for his future contributions to the medical field.

šŸ„ Professional Endeavors

After completing his degree, Zewen Cheng undertook a comprehensive three-year residency at The First Affiliated Hospital of Soochow University. From July 2019 to June 2022, he refined his expertise in thoracic surgery, gaining invaluable hands-on experience in clinical diagnostics, patient management, and surgical procedures. His tenure in the residency program enabled him to work closely with senior specialists, tackling complex cases and honing his skills. In September 2022, he advanced to the role of Attending Physician at Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, where he seamlessly integrates Western and Traditional Chinese medical treatments to provide holistic patient care.

šŸ”¬ Contributions and Research Focus

Zewen Cheng is deeply invested in the evolving landscape of thoracic surgery. His research interests span innovative surgical techniques, minimally invasive procedures, and the integration of Traditional Chinese Medicine (TCM) in thoracic disease management. With proficiency in data analysis software such as R and SPSS, he actively contributes to medical research, utilizing statistical methodologies to enhance clinical decision-making. His work emphasizes the importance of interdisciplinary approaches in improving patient outcomes and advancing the field of thoracic surgery.

šŸ† Accolades and Recognition

Throughout his medical career, Zewen Cheng has been recognized for his dedication and expertise in thoracic surgery. Successfully completing the standardized residency training at The First Affiliated Hospital of Soochow University, he demonstrated exceptional skill and commitment to surgical excellence. His fluency in Medical English (CET-6) has enabled him to collaborate effectively with international medical professionals, further expanding his impact within the global medical community.

šŸ’Ŗ Impact and Influence

As an Attending Physician, Zewen Cheng plays a crucial role in supervising and training junior doctors, fostering the next generation of thoracic surgeons. His ability to blend traditional and modern medical practices ensures that patients receive comprehensive treatment tailored to their specific needs. His contributions extend beyond direct patient care, as he actively participates in multidisciplinary teams, shaping the future of thoracic surgery through collaborative innovation and knowledge sharing.

šŸŒŸ Legacy and Future Contributions

With a strong foundation in both clinical practice and research, Zewen Cheng aspires to push the boundaries of thoracic surgery through continuous learning and innovation. His commitment to integrating Traditional Chinese Medicine with contemporary surgical techniques presents new avenues for patient care and treatment efficacy. Looking ahead, he envisions contributing to groundbreaking research, refining surgical methodologies, and mentoring future medical professionals, leaving a lasting legacy in the field of thoracic surgery.

 

Publication

Title: Exploring the Causal Relationship Between Frailty and Chronic Obstructive Pulmonary Disease: Insights From Bidirectional Mendelian Randomization and Mediation Analysis
Authors: Zewen Cheng, Jian Wu, Chun Xu, Xiaokun Yan
Year: 2025

 

šŸ† Conclusion

Zewen Cheng is a strong candidate for the Young Scientist Award, given his clinical expertise, innovative approach to medicine, and commitment to training future surgeons. Strengthening his research impact and expanding international collaborations would further solidify his position as a leading young scientist in thoracic surgery.

 

 

Basanta Kumar das | Immunology | Best Researcher Award

Dr. Basanta Kumar das | Immunology | Best Researcher Award

Dr. Basanta Kumar das, Central Inland Fisheries Research Institute,Ā  India.

Dr. Basanta Kumar Das is a distinguished fisheries scientist and Director of ICAR-Central Inland Fisheries Research Institute (CIFRI), Kolkata. Born in Odisha in 1966, he pursued his Ph.D. from Orissa University of Agriculture and Technology and later completed his postdoctoral research at FRS Marine Lab, Scotland. Throughout his career, he has significantly contributed to disease management in open-water fish ecosystems, aquaculture health management, molecular epidemiology of fish diseases, and antiviral gene expression studies in carps. He has also developed medicines for ornamental fish diseases, immunostimulants, and bioactive compounds from algae and plant derivatives.

Profile

Google Scholar

 

Early Academic Pursuits šŸŽ“

Born on March 20, 1966, in Athilabaj, District Balasore, Odisha, Dr. Basanta Kumar Das embarked on an academic journey that laid the foundation for his remarkable contributions to fisheries science. He pursued his education at the Orissa University of Agriculture and Technology, earning his Ph.D. in 1998. His relentless thirst for knowledge led him to a prestigious post-doctoral fellowship at the FRS Marine Lab in Aberdeen, Scotland, UK (2006ā€“2007), where he deepened his expertise in aquatic health and disease management. His early academic pursuits cemented his position as a leading authority in fisheries research, blending traditional knowledge with modern scientific approaches.

Professional Endeavors and Leadership šŸŒŠ

Dr. Das has dedicated his career to revolutionizing inland fisheries and aquaculture. Currently serving as the Director of ICAR-Central Inland Fisheries Research Institute (CIFRI), Kolkata, he has spearheaded numerous initiatives to enhance aquatic resource management. Beyond his directorial role, he serves as the President of the Inland Fisheries Society of India, President of the Professional Fisheries Graduates Forum, and President of the Orissa Fisheries College Alumni Association. These leadership positions reflect his unwavering commitment to fostering scientific communities and strengthening professional networks in fisheries and aquatic sciences.

Contributions and Research Focus šŸ”¬

Dr. Dasā€™s research has been instrumental in addressing critical challenges in fisheries science. His expertise spans diverse areas, including disease management in open-water fish ecosystems, health management in aquaculture, and molecular epidemiological studies of fish diseases. His groundbreaking work in anti-viral gene expression studies of carps has opened new frontiers in aquatic disease control. Additionally, he has contributed significantly to the development of medicines for ornamental fish diseases, innovative immunostimulants, and bioactive compounds derived from algae and plant derivatives. His pioneering research on enclosure culture in inland open waters has transformed sustainable fisheries management, providing innovative solutions for fish conservation and productivity.

Accolades and Recognition šŸ†

Dr. Dasā€™s illustrious career has been adorned with numerous prestigious awards. He received the Jawaharlal Nehru Award for outstanding postgraduate research from ICAR, followed by the Lal Bahadur Shastri Young Scientist Award (1999ā€“2000). His excellence in fisheries science earned him the Dr. M.S. Swaminathan Award (2011) and the Krushi Ratna Award (2016). His remarkable contributions were further acknowledged with the Eminent Zoologist of the Year Award (2017), the Ganesh Chandra Vidyarthi Award (2018), and the Best Annual Report Award (2019). In recognition of his institutional leadership, ICAR-CIFRI received the Sardar Patel Outstanding ICAR Institution Award (2020) under his direction. The pinnacle of his accolades includes the Rafi Ahmed Kidwai Award (2020) for outstanding research in agricultural sciences and the Agri-Food Empowering India Award (2021).

Impact and Influence on the Global Scientific Community šŸŒ

Dr. Das has built strong international collaborations, expanding the reach of Indian fisheries research to the global stage. He has established vital partnerships with WorldFish, FAO, NACA, GIZ, SAARC, BOBP, IUCN, World Bank, and leading universities such as RMIT University, University of Manitoba, University of Waterloo, and University of Aberdeen. His role in policy advisory and scientific development has helped shape sustainable aquaculture practices worldwide. Additionally, his commitment to academic mentorship is reflected in his guidance of 25 Ph.D. scholars, 35 Masterā€™s students, two postdoctoral researchers, and two international scholars. His contribution to fisheries education and scientific discourse is further amplified by 13 MoUs with government departments, commercial enterprises, and research collaborations.

Scientific Contributions and Publications šŸ“š

Dr. Dasā€™s prolific research output stands as a testament to his enduring impact on fisheries science. With over 375 international publications and 8,286 citations, his work has significantly influenced the global scientific community. His extensive research on fish diseases, bioactive compounds, and molecular diagnostics has provided critical insights into improving fish health management and enhancing aquaculture sustainability. His contributions continue to be referenced by researchers, policymakers, and industry leaders worldwide, reinforcing his position as a thought leader in aquatic sciences.

Legacy and Future Contributions šŸš€

As a visionary in fisheries science, Dr. Basanta Kumar Dasā€™s contributions extend beyond research and academia. His work has set new benchmarks in disease management, aquaculture sustainability, and molecular epidemiology. His leadership in inland fisheries research will continue to drive innovations in biotechnological advancements for disease prevention, eco-friendly aquaculture techniques, and sustainable fisheries management. With a steadfast commitment to environmental conservation and scientific excellence, his legacy will inspire future generations of researchers to explore the uncharted depths of aquatic sciences and contribute to a more resilient and productive fisheries sector.

Publication

 

  • Effect of Achyranthes aspera on the immunity and survival of Labeo rohita infected with Aeromonas hydrophila
    Authors: YV Rao, BK Das, P Jyotyrmayee, R Chakrabarti
    Year: 2006

 

  • Toxicity of cypermethrin in Labeo rohita fingerlings: biochemical, enzymatic and haematological consequences
    Authors: BK Das, SC Mukherjee
    Year: 2003

 

  • Effect of Allium sativum on the immunity and survival of Labeo rohita infected with Aeromonas hydrophila
    Authors: S Sahu, BK Das, BK Mishra, J Pradhan, N Sarangi
    Year: 2007

 

  • Effect of long term administration of dietary Ī²-glucan on immunity, growth and survival of Labeo rohita fingerlings
    Authors: CK Misra, BK Das, SC Mukherjee, P Pattnaik
    Year: 2006

 

  • Effect of Magnifera indica kernel as a feed additive on immunity and resistance to Aeromonas hydrophila in Labeo rohita fingerlings
    Authors: S Sahu, BK Das, J Pradhan, BC Mohapatra, BK Mishra, N Sarangi
    Year: 2007

 

  • Effect of multiple injections of Ī²-glucan on non-specific immune response and disease resistance in Labeo rohita fingerlings
    Authors: CK Misra, BK Das, SC Mukherjee, P Pattnaik
    Year: 2006

 

  • Spatial distribution of meso and microplastics in the sediments of river Ganga at eastern India
    Authors: DJ Sarkar, SD Sarkar, BK Das, RK Manna, BK Behera, S Samanta
    Year: 2019

 

  • Emergence of tilapia lake virus associated with mortalities of farmed Nile tilapia Oreochromis niloticus (Linnaeus 1758) in India
    Authors: BK Behera, PK Pradhan, TR Swaminathan, N Sood, P Paria, A Das, …
    Year: 2018

 

  • A histopathological study of carp (Labeo rohita) exposed to hexachlorocyclohexane
    Authors: BK Das, SC Mukherjee
    Year: 2000

 

  • A predatorā€“prey interaction model with self and cross-diffusion
    Authors: B Dubey, B Das, J Hussain
    Year: 2001

 

Conclusion

Dr. Basanta Kumar Dasā€™s legacy in fisheries science is marked by groundbreaking research, transformative leadership, and unwavering dedication to advancing aquatic health, sustainable fisheries, and innovative disease management solutions. His scientific endeavors have revolutionized inland aquaculture, bridging the gap between traditional fisheries practices and modern molecular research. Through his mentorship, institutional leadership, and global collaborations, he continues to shape the next generation of fisheries scientists while working toward sustainable and eco-friendly aquaculture solutions. His lifelong commitment to fisheries research ensures that his contributions will have a lasting impact on the global fisheries sector, environmental conservation, and food security.

Dinh Phong Son | CircRNA | Best Researcher Award

Dr. Dinh Phong Son | CircRNA | Best Researcher Award

Dr. DINH PHONG SON, DUYTAN UNIVERSITY, Vietnam.

Dr. Dinh Phong Son is a researcher specializing in laboratory medicine techniques with a Ph.D. in Molecular Medicine from Guangxi Medical University, China. His research focuses on modern molecular biology techniques, particularly the identification of potential biomarkers for early disease diagnosis and targeted therapy. His studies explore systemic diseases such as diabetes, cardiovascular diseases, and cancer, emphasizing gene editing technologies like CRISPR/Cas9. His recent publications contribute to the understanding of regulatory RNA networks and their implications in disease mechanisms, providing a foundation for future studies on molecular interactions and targeted drug development.

Profile

Orcid

 

šŸŽ“ Early Academic Pursuits

From the very beginning of my academic journey, I was deeply fascinated by the intricate mechanisms of life at a molecular level. My pursuit of knowledge led me to study Laboratory Medicine Technique at Hue University of Medicine and Pharmacy, Vietnam, where I honed my expertise in diagnostic methodologies and medical laboratory sciences. With an insatiable thirst for discovery, I furthered my education by earning a Doctorate (Ph.D.) in Molecular Medicine from Guangxi Medical University, China. This academic foundation set the stage for my dedication to the field of molecular biology, shaping my vision to explore genetic markers and innovative diagnostic tools.

šŸ‘©ā€šŸŽ“ Professional Endeavors

Currently, I serve at Duy Tan University, College of Medicine and Pharmacy, where I actively contribute to research, mentoring, and academic discourse. My work primarily revolves around molecular diagnostics, genetic analysis, and disease biomarker identification, aiming to bridge the gap between molecular biology and clinical applications. With advancements in next-generation sequencing (NGS) and bioinformatics databases, I continually seek new pathways to enhance the precision of disease detection and treatment strategies.

šŸ§Ŗ Contributions and Research Focus

My research is deeply rooted in molecular medicine, focusing on the identification of potential biomarkers for the early diagnosis of systemic diseases such as diabetes, cardiovascular diseases, stroke, and cancer. My investigations also extend to exploring gene targets for pharmacological studies, assisting in drug development through the modulation of gene expression using cutting-edge technologies like CRISPR/Cas9, gene overexpression, and silencing approaches. Furthermore, my work delves into the complex LncRNA/CircRNA/miRNA/gene/protein-drug interaction networks, paving the way for theoretical models that could revolutionize targeted therapy research.

 

šŸ’Ž Impact and Influence

The impact of my research extends beyond academia, as it plays a crucial role in early disease screening, personalized medicine, and therapeutic advancements. By leveraging molecular networks, I aim to facilitate the development of precise diagnostic tools and gene-targeted interventions, significantly improving patient outcomes. My research findings have the potential to reshape biomedical applications and create avenues for innovative treatment strategies across various diseases.

šŸŒŸ Legacy and Future Contributions

Looking ahead, my aspirations remain steadfast in expanding molecular biology research, particularly in uncovering novel biomarkers and refining gene-editing techniques. As the field continues to evolve, I hope to contribute to the refinement of therapeutic gene modifications and biomarker-based diagnostics. With sustained efforts and collaborations, I envision a future where my research serves as a cornerstone for breakthroughs in precision medicine, targeted gene therapy, and advanced molecular diagnostics.

šŸ‘Øā€šŸ’¼ Professional Collaborations and Memberships

As an active member of the scientific community, I engage in collaborations and professional affiliations to foster knowledge exchange and multidisciplinary research. My involvement in editorial appointments, consultancy projects, and industry partnerships enables me to extend my research impact, ensuring that molecular medicine continues to advance for the benefit of humanity.

 

Publication

  • Title: Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on Microarray Data analysis, molecular docking, and dynamic simulation
    Authors: PhongSon Dinh, ChauMyThanh Tran, ThiPhuongHoai Dinh, Hai-Anh Ha, Aigul Utegenova, Awais Ali, Abdulaziz Alamri
    Year: 2025

 

  • Title: Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression by sponging miRNA-338-3p via regulating the expression of ETS1
    Authors: PhongSon Dinh, ChauMyThanh Tran, ThiPhuongHoai Dinh, Awais Ali, ShangLing Pan
    Year: 2024

 

  • Title: Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of bioinformatics data
    Authors: ChauMyThanh Tran, PhongSon Dinh
    Year: 2024

 

  • Title: Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as potential biomarker for coronary heart disease
    Authors: PhongSon Dinh, JunHua Peng, ThanhLoan Tran, DongFeng Wu, ChauMyThanh Tran, ThiPhuongHoai Dinh, ShangLing Pan
    Year: 2023

 

  • Title: Construction of miRNAs and gene expression profiles associated with ischemic cardiomyopathy: Bioinformatics analysis
    Authors: PhongSon Dinh, Jun-Hua Peng, ChauMyThanh Tran, ThanhLoan Tran, Shang-Ling Pan
    Year: 2022

 

Conclusion

Dr. Son’s research plays a crucial role in advancing molecular biology by identifying key biomarkers and regulatory networks for disease screening and treatment. His work in gene-targeted therapy and RNA interaction networks lays the groundwork for future innovations in precision medicine. Despite challenges in resources and time, his commitment to molecular research aims to drive further advancements in understanding and treating complex diseases.